As of May 22
| -0.27 / -4.50%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 6.75, with a high estimate of 6.75 and a low estimate of 6.75. The median estimate represents a +17.80% increase from the last price of 5.73.
The current consensus among 1 polled investment analysts is to Hold stock in CorMedix Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.